Copper Tripeptide-1 (GHK-Cu)
The GLP-1 receptor agonist class began with compounds like liraglutide and exenatide, targeting only the GLP-1R
Step 2: Review the Trial Details Carefully Not surprisingly, criteria for clinical trials can be very specific
The molecule was first isolated by Pickart in 1973 as the active component of human albumin fraction responsible for inducing older liver tissue to synthesize proteins characteristic of younger tissue an observation that led to subsequent decades of research into GHK-Cus effects on wound healing, skin regeneration, gene expression, and cellular senescence
If you're unsure which option is right for you, discuss your symptoms, medical history, and lab results with your healthcare provider before beginning supplementation
This age-related decline correlates with decreasing tissue regenerative capacity